| Management number | 222232263 | Release Date | 2026/05/04 | List Price | US$19.98 | Model Number | 222232263 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
A Practical Manual for Anti-Amyloid Therapy in Clinical PracticeThe definitive clinical guide for implementing disease-modifying Alzheimer's treatmentsThe FDA approval of lecanemab (LEQEMBI®) and donanemab (KISUNLA®) has ushered in a new era of Alzheimer's disease treatment—but translating groundbreaking science into safe, effective clinical care requires practical guidance that didn't exist. Until now.A Practical Manual for Anti-Amyloid Therapy in Clinical Practice is the comprehensive, evidence-based resource that neurologists, dementia specialists, and multidisciplinary care teams need to confidently implement anti-amyloid immunotherapy programs.WHAT'S INSIDE:Patient Selection Made Clear — Step-by-step eligibility criteria, contraindications, and the critical role of APOE genotyping in risk stratificationARIA Mastery — Complete protocols for monitoring, detecting, grading, and managing amyloid-related imaging abnormalities, the most significant safety consideration in anti-amyloid therapyDrug-Specific Protocols — Side-by-side comparison of lecanemab and donanemab dosing, infusion procedures, MRI surveillance schedules, and treatment duration strategiesReal-World Clinical Scenarios — Practical guidance for anticoagulation management, atrial fibrillation, post-ARIA rechallenge decisions, and transitioning between therapiesRegulatory Compliance — CMS registry requirements, Medicare coverage criteria, quality metrics, and documentation standards for audit readinessReady-to-Use Tools — Quick-reference pocket cards, EHR-ready order sets, patient education materials, and informed consent frameworksFULLY UPDATED FOR 2026:FDA-cleared plasma p-tau217 blood biomarker testingSubcutaneous lecanemab (LEQEMBI IQLIK™) maintenance dosingPipeline therapies including trontinemab and remternetugLatest ARIA management recommendations and real-world safety dataWHO THIS BOOK IS FOR:Neurologists and dementia specialists initiating anti-amyloid therapy programsBehavioral Neurology & Neuropsychiatry fellows in trainingNurse practitioners and physician assistants in memory careInfusion center nurses and radiology teamsMemory clinic administrators building treatment infrastructureFROM THE FRONT LINES OF ALZHEIMER'S CARE:Developed at a leading Alzheimer's Disease Research Center with real-world clinical experience, this manual bridges the gap between pivotal trial data and the practical realities of treating patients in your clinic.Whether you're launching a new anti-amyloid therapy program or optimizing an existing one, this manual provides the protocols, checklists, and clinical pearls you need to deliver safe, effective, patient-centered care. Read more
| ISBN13 | 979-8246408094 |
|---|---|
| Language | English |
| Publisher | Independently published |
| Dimensions | 5 x 0.36 x 8 inches |
| Book 1 of 1 | Clinical Masterclass |
| Item Weight | 8 ounces |
| Print length | 151 pages |
| Publication date | March 2, 2026 |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form